Methotrexate Sodium (Trexall/Xatmep)
ChemotherapyApproved for: NSCLC, SCLC Methotrexate Sodium (Trexall/ Xatmep) Related Research News FDA Approves Repotrectinib for Locally Advanced or Metastatic ROS1+ NSCLCClinical Research Demonstrates Positive Impact of Genomic Testing for Patients with Non-Small Cell Lung CancerA Multicenter Study on the...